Atrium Therapeutics, Inc. · NASDAQ:RNA
Flanagan W. Michael had 22,812 Atrium Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Sep 18, 2026 · Filed Sep 22, 2026
On Sep 18, 2026, Flanagan W. Michael (Director) had 22,812 Atrium Therapeutics, Inc. shares withheld for tax at US$8.95 for US$204K, leaving 31,974 shares. Filed Sep 22, 2026 (Form 4).
- Withheld for tax
- 22,812 shares
- Price
- US$8.95
- Value
- US$204K
- Holding after
- 31,974 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | Shares withheld for tax | 22,812 | US$8.95 | 31,974 | Direct |